Management of malignant hypertension complicated by renal insufficiency. A follow-up study.
D000328:Adult; D000368:Aged; D001158:Arteries / Q000473:pathology; D001344:Autopsy; D001581:Benzothiadiazines; D004232:Diuretics; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D005919:Glomerular Filtration Rate; D006145:Guanethidine / Q000627:therapeutic use; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use; D006965:Hyperplasia; D006974:Hypertension, Malignant / Q000188:drug therapy* / Q000209:etiology / Q000401:mortality / Q000473:pathology / Q000503:physiopathology; D007668:Kidney / Q000098:blood supply; D007676:Kidney Failure, Chronic / Q000150:complications* / Q000473:pathology / Q000503:physiopathology / Q000628:therapy; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis; D049993:Sodium Chloride Symporter Inhibitors / Q000627:therapeutic use
D001581:Benzothiadiazines; D004232:Diuretics; D049993:Sodium Chloride Symporter Inhibitors; D006830:Hydralazine; D006145:Guanethidine